AGEN
Agenus Inc
Price:  
10.70 
USD
Volume:  
286,336.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Agenus EV/EBITDA

-948.5%
Upside

As of 2024-05-21, the EV/EBITDA ratio of Agenus Inc (AGEN) is -1.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Agenus's latest enterprise value is 177.71 mil USD. Agenus's TTM EBITDA according to its financial statements is -124.95 mil USD. Dividing these 2 quantities gives us the above Agenus EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.4x - 17.5x 12.0x
Forward P/E multiples 13.1x - 21.0x 18.1x
Fair Price (78.53) - (106.00) (90.79)
Upside -833.9% - -1090.7% -948.5%
10.70 USD
Stock Price
(90.79) USD
Fair Price

Agenus EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-20 -1.42
2024-05-17 -1.45
2024-05-16 -1.39
2024-05-15 -1.44
2024-05-14 -1.42
2024-05-13 -1.49
2024-05-10 -1.39
2024-05-09 -1.59
2024-05-08 -1.55
2024-05-07 -1.63
2024-05-06 -1.79
2024-05-03 -1.81
2024-05-02 -1.72
2024-05-01 -1.84
2024-04-30 -1.65
2024-04-29 -1.76
2024-04-26 -1.58
2024-04-25 -1.03
2024-04-24 -0.89
2024-04-23 -0.73
2024-04-22 -0.62
2024-04-19 -0.55
2024-04-18 -0.49
2024-04-17 -0.56
2024-04-16 -0.71
2024-04-15 -0.74
2024-04-12 -1.01
2024-04-11 -1.13
2024-04-10 -1.13
2024-04-09 -1.26
2024-04-08 -1.20
2024-04-05 -1.32
2024-04-04 -1.33
2024-04-03 -1.41
2024-04-02 -1.35
2024-04-01 -1.59
2024-03-28 -1.57
2024-03-27 -1.49
2024-03-26 -1.43
2024-03-25 -1.50
2024-03-22 -1.46
2024-03-21 -1.51
2024-03-20 -1.49
2024-03-19 -1.51
2024-03-18 -1.41
2024-03-15 -1.44
2024-03-14 -1.63
2024-03-13 -1.82
2024-03-12 -1.86
2024-03-11 -1.87